SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-144636
Filing Date
2016-09-14
Accepted
2016-09-14 16:16:18
Documents
1
Period of Report
2016-09-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4204
  Complete submission text file 0001104659-16-144636.txt   5641
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 3122 STERLING CIRCLE SUITE 200 BOULDER CO 80301
Business Address
Rodman David Malcom (Reporting) CIK: 0001672659 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 161885255